Screener
Inhibrx Biosciences, Inc. INBX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | MARCH 31, 2026 | DECEMBER 31, 2025 |
|---|---|---|
| Total current assets | 171,341 | 132,832 |
| Property and equipment, net | 3,196 | 3,733 |
| Operating right-of-use asset | 5,052 | 5,535 |
| Other non-current assets | 4,378 | 4,378 |
| Total assets | $183,967 | $146,478 |
| Liabilities and stockholders’ equity (deficit) | ||
| Current liabilities: | ||
| Accounts payable | $8,762 | $5,944 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s other non-current assets?
- Inhibrx Biosciences, Inc. (INBX) reported other non-current assets of $4.38M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s other non-current assets changed year-over-year?
- Inhibrx Biosciences, Inc.'s other non-current assets decreased by 35.6% year-over-year, from $6.8M to $4.38M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s other non-current assets?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s other non-current assets has grown at a 17.6% compound annual growth rate (CAGR), from $3.16M to $4.38M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Inhibrx Biosciences, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude